The efficiency of HRCT for Assessing Severity in COVID-19 Patients


PDF PDF

Keywords

COVID-19
HRCT
RTPCR

How to Cite

1.
The efficiency of HRCT for Assessing Severity in COVID-19 Patients. Planet (Barisal) [Internet]. 2022 Aug. 15 [cited 2025 Aug. 23];6(01):62-6. Available from: https://www.bdjournals.org/index.php/planet/article/view/171

Abstract

The COVID-19 pandemic's impact resulted in countless deaths. In addition to RT-PCR, the HRCT technique is gaining popularity for determining severity. The primary aim of the research is to determine the accuracy of HRCT in determining the severity of cvoid-19 patients. This crosssectional study was carried out at a tertiary medical hospital from September 2020 to October 2021. A total of 100 confirmed cases of COVID-19 pneumonia were admitted to hospitals and underwent HRCT chest included in the study. In the research, 56% of patients were between the ages of 20 and 40, 14% of patients were under the age of 20, and only 30% of patients were above the age of 40. About 35% of the patients had a history of smoking, 55% had diabetes, and 40% had HTN status. Thirty percent developed a cough and fever, followed by twenty percent who had only a cough, twenty-five percent who had a cough, fever, and body ache, and fifteen percent who had respiratory symptoms.All five lobes of the lungs were involved in 96% of the cases, with the right lower lobe being involved in 91% of the cases and the right middle lobe being the least frequent location of involvement. Additionally, 31%, or the majority of patients, had a total severity score ranging from 1 to 5. Among others, the sequential distribution of total severity scores ranges from 6 to 10 (24 %), 11 to 15 (22 %), 16 to 20 (17%), and 0 (4%). In terms of total percentage of lung involvement, the highest number of patients (30%) was found in the 1-25 percent range, while the highest proportion of lung involvement (76–100 percent) was found in (18 percent ). For COVID-19 patients, an HRCT scan of the chest is an excellent diagnostic and therapeutic tool for COVID19 patients. It is an important predictor of future outcomes. When RT-PCR results are inconclusive, HRCT may be a viable option in symptomatic individuals. It is vital for radiologists and physicians to be familiar with the varied CT presentations. It will assist in the care of the patient.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2022 The Planet

How is your experience today?